Clinical Trials in Florida

Showing 6001-6020 of 9,710 trials

Mitroflow DL Post Approval Study- North America

NCT02351726

Prospective, non-randomized, multicenter post-approval study to collect long term clinical and echographic data on Mitroflow DL patients.

Aortic StenosisAortic RegurgitationAortic Valve Insufficiency+6 more

LivaNova186 participantsStarted Mar 2015

Los Angeles, California, United States • San Diego, California, United States • Jacksonville, Florida, United States +10 more locations

COMPLETEDPhase 338 miles

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

NCT03759197

This Phase 3 study (Study 305) has been designed to determine and compare the efficacy and safety of 188-0551 Spray and Vehicle Spray applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Spray or Vehicle Spray) to all psoriasis plaques within the designated Treatment Area twice daily for four weeks (Study Day 29), unless the investigator verifies the subject's psoriasis has cleared at Day 15, then test article application will be for 2 weeks (Study Day 15).

Plaque Psoriasis

Therapeutics, Inc.206 participantsStarted Nov 2018

Fort Smith, Arkansas, United States • Fountain Valley, California, United States • Fremont, California, United States +9 more locations

Mitroflow DL Post Approval Study- North America

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

Find Trials by Condition in Florida

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Cornea Donor Study

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101